Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ziyan Pan

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Annals of Hepatology|March 28, 2025
Metabolic dysfunction and kidney disease risk in individuals with MAFLDZiyan Pan, Mohammed Eslam
Annals of Hepatology|June 11, 2024
MAFLD or MASLD: Let the evidence decide againZiyan Pan, Mohammed Eslam
Journal of Hepatology|March 31, 2024
The MASLD criteria overlook a number of adolescent patients with severe steatosisZiyan Pan, Mohammed Eslam,
DNA and Cell Biology|May 31, 2024
MERTK and Fibrosis: A New Target for TherapyZiyan Pan, Mohammed Eslam
Liver International : Official Journal of the International Association for the Study of the Liver|May 27, 2024
Bringing evidence to the MAFLD-MASLD debateZiyan Pan, Mohammed Eslam
Hepatology International|October 17, 2022
Metabolically healthy obese and MAFLD: does weight status alone matter?Ziyan Pan, Mohammed Eslam
Hepatology International|February 4, 2026
Diagnostic criteria for fatty liver disease: lessons from other diseasesShadi Zerehpoosh, Ziyan Pan, Mohammed Eslam
Liver International : Official Journal of the International Association for the Study of the Liver|January 22, 2026
Epigenetic Aging Biomarkers in Lean MAFLDZiyan Pan, Shadi Zerehpoosh, Mohammed Eslam
Clinical and Molecular Hepatology|February 5, 2026
Reply to "A Call for More Efforts to Incorporate Liver in the Metabolic Health Framework"Shadi Zerehpoosh, Ziyan Pan, Mohammed Eslam
Clinical and Molecular Hepatology|January 18, 2026
A Call for More Efforts to Incorporate Liver in the Metabolic Health FrameworkShadi Zerehpoosh, Ziyan Pan, Mohammed Eslam
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Annals of Hepatology|March 28, 2025
Metabolic dysfunction and kidney disease risk in individuals with MAFLDZiyan Pan, Mohammed Eslam
Annals of Hepatology|June 11, 2024
MAFLD or MASLD: Let the evidence decide againZiyan Pan, Mohammed Eslam
Journal of Hepatology|March 31, 2024
The MASLD criteria overlook a number of adolescent patients with severe steatosisZiyan Pan, Mohammed Eslam,
DNA and Cell Biology|May 31, 2024
MERTK and Fibrosis: A New Target for TherapyZiyan Pan, Mohammed Eslam
Liver International : Official Journal of the International Association for the Study of the Liver|May 27, 2024
Bringing evidence to the MAFLD-MASLD debateZiyan Pan, Mohammed Eslam
Hepatology International|October 17, 2022
Metabolically healthy obese and MAFLD: does weight status alone matter?Ziyan Pan, Mohammed Eslam
Hepatology International|February 4, 2026
Diagnostic criteria for fatty liver disease: lessons from other diseasesShadi Zerehpoosh, Ziyan Pan, Mohammed Eslam
Liver International : Official Journal of the International Association for the Study of the Liver|January 22, 2026
Epigenetic Aging Biomarkers in Lean MAFLDZiyan Pan, Shadi Zerehpoosh, Mohammed Eslam
Clinical and Molecular Hepatology|February 5, 2026
Reply to "A Call for More Efforts to Incorporate Liver in the Metabolic Health Framework"Shadi Zerehpoosh, Ziyan Pan, Mohammed Eslam
Clinical and Molecular Hepatology|January 18, 2026
A Call for More Efforts to Incorporate Liver in the Metabolic Health FrameworkShadi Zerehpoosh, Ziyan Pan, Mohammed Eslam
Pageof 6